EXANE DERIVATIVES - VIKING THERAPEUTICS INC ownership

VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 118 filers reported holding VIKING THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.

Quarter-by-quarter ownership
EXANE DERIVATIVES ownership history of VIKING THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$83,323,000
-56.0%
27,776
-7.9%
0.02%
-48.9%
Q3 2021$189,304,000
+34.1%
30,145
+25.7%
0.04%
+40.6%
Q2 2021$141,198,000
-50.5%
23,973
-46.8%
0.03%
-61.0%
Q1 2021$285,131,000
-1.2%
45,082
-12.1%
0.08%
-3.5%
Q4 2020$288,716,000
+10.5%
51,284
+14.3%
0.08%
+11.8%
Q3 2020$261,170,000
-17.4%
44,877
+2.3%
0.08%
-10.6%
Q2 2020$316,303,000
+27.1%
43,873
-17.5%
0.08%
+21.4%
Q1 2020$248,843,00053,1740.07%
Other shareholders
VIKING THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Affinity Asset Advisors, LLC 622,249$10,360,4463.42%
GREAT POINT PARTNERS LLC 1,000,000$16,650,0003.27%
Ghost Tree Capital, LLC 600,000$9,990,0002.95%
SILVERARC CAPITAL MANAGEMENT, LLC 380,000$6,327,0002.61%
Integral Health Asset Management, LLC 727,100$12,106,2152.44%
Sio Capital Management, LLC 250,000$4,162,5002.06%
Boxer Capital, LLC 2,000,000$33,3001.64%
DAFNA Capital Management LLC 319,155$5,313,9311.59%
5AM Venture Management, LLC 350,000$5,827,5001.49%
Monashee Investment Management LLC 300,000$4,995,0001.38%
View complete list of VIKING THERAPEUTICS INC shareholders